Investigation of Leptin, Leukemia Inhibitory Factor (LIF), and IL-6 Serum Levels in Myeloid Leukemia

Journal Title: Iranian Journal of Blood and Cancer - Year 2010, Vol 2, Issue 4

Abstract

Background: Leptin has been implicated in the differentiation and proliferation of hematopoietic cells. Leukemia inhibitory factor (LIF) may play an important role, along with Interleukin-6 (IL-6) and granulocyte colony stimulating factor (G- CSF), in the regulation of early hematopoietic stem cells. The aim of the study was to evaluate serum level of leptin, LIF, and IL-6 in myeloid leukemia patients. Materials and Methods: We investigated serum level of leptin, LIF, and IL-6 levels, body mass index, hemoglobin, and hematocrit in 30 myeloid leukemia patients (15 patients with acute and 15 with chronic myeloid leukemia) before chemotherapy, and compared the results with 15 healthy controls. Results: Leptin, LIF and IL-6 serum levels, and lipid profile in myeloied leukemic patient was significantly different from the control group (p<0.05). The relationship between leptin and BMI was statistically significant in control group, whereas in the patient group, there were no significant relationship between leptin and BMI. Conclusion: Lipid profile and leptin, LIF, and IL-6 serum levels of leukemic patients were significantly different from normal population.

Authors and Affiliations

Shaban Alizadeh, Shahab Bohloli, Ali Abedi, Seyed Hadi Mousavi, Hossein Dargahi, Behzad Jafarzadeh, Nourooz Hamrang

Keywords

Related Articles

Treatment of a Child with Refractory Acute Myeloid Leukemia with Humanized Anti-CD33 Monoclonal Antibody: A Case Report and Review of Drug Development

Background: The induction chemotherapy regimen for acute myeloid leukemia has evolved as once induction is completed patients progress through the consolidation phase and achieve remission in 76% of cases. For patients w...

Role of Ghrelin in Cancer

Cancer is one of the most fatal diseases in human beings which annually leads to death of 30000 individuals in Iran. Prevention, diagnosis and treatment of cancer is one of the major scientific challenges all around the...

Frequency of Blood Components Wastage and Associated Factors in Yazd Healthcare Centers

Background: Excessive ordering of blood components imposes heavy costs to blood transfusion centers and increases the amount of blood product wastage due to lack of their use. In recent years, attempts have been made aga...

University Students Awareness and Attitude towards Blood Donation in Kerman City

Background: Blood transfusion is one of the most crucial needs of the society in multiple diseases and injuries. The only source of blood is donation. Students consist a large and healthy group who are able of providing...

Hyperimmunes Plasma Procurement and Products

This article has no abstract.

Download PDF file
  • EP ID EP376978
  • DOI -
  • Views 68
  • Downloads 0

How To Cite

Shaban Alizadeh, Shahab Bohloli, Ali Abedi, Seyed Hadi Mousavi, Hossein Dargahi, Behzad Jafarzadeh, Nourooz Hamrang (2010). Investigation of Leptin, Leukemia Inhibitory Factor (LIF), and IL-6 Serum Levels in Myeloid Leukemia. Iranian Journal of Blood and Cancer, 2(4), 95-100. https://europub.co.uk/articles/-A-376978